Navigation Links
Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib at 53rd American Society of Hematology Annual Meeting
Date:11/7/2011

oster I
  • Abstract #1877

  • A Phase 1b/2 Study of Prolonged Infusion Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma: Updated Efficacy and Tolerability from the Completed 20/56 mg/m2 Expansion Cohort of PX-171-007

    • Dr. Kyriakos Papadopoulos, South Texas Accelerated Research Therapeutics
    • Sunday, December 11, 2011, 6:00 – 8:00 p.m., Hall GH
    • Poster session: Myeloma - Therapy, excluding Transplantation: Poster II
    • Abstract #2930

    Phase 2 Study of Carfilzomib Combined with Other Anti-Myeloma Agents in Relapsed-Refractory Multiple Myeloma - Updates on the UARK Compassionate Use Protocol

    • Dr. Saad Usmani, University of Arkansas for Medical Sciences
    • Sunday, December 11, 2011, 6:00 – 8:00 p.m., Hall GH
    • Poster session: Myeloma - Therapy, excluding Transplantation: Poster II
    • Abstract #2947

    The Speed of Response to Single-Agent Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma: An Exploratory Analysis of Results from Two Multicenter Phase 2 Clinical Trials

    • Dr. Michael Wang, The University of Texas MD Anderson Cancer Center
    • Monday, December 12, 2011, 6:00 – 8:00 p.m., Hall GH
    • Poster session: Myeloma – Therapy, excluding Transplantation: Poster III
    • Abstract #3969

    Carfilzomib Development Program
    Carfilzomib is being studied in several clinical trials either as a single-agent or in combination with other therapies, including:

    • A Phase 3 clinical trial, known as the ASPIRE trial, is evaluating the combination of lenalidomide and low dose dexamethasone with or without carfilzomib in patients with relapsed multiple myeloma who have received one to three prior therapies. The com
      '/>"/>

    SOURCE Onyx Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights
    2. Planet Biopharmaceuticals, Inc. Divests Assets of Allergy Control Products, Inc.
    3. Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results
    4. Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
    5. Vanda Pharmaceuticals Reports Third Quarter 2011 Results
    6. Quanticel Pharmaceuticals Enters Into Strategic Cancer Drug Discovery Collaboration With Celgene Corporation
    7. Cadence Pharmaceuticals Reports Third Quarter 2011 Financial Results
    8. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
    9. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results
    10. Onyx Pharmaceuticals Reports Third Quarter 2011 Financial Results
    11. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2011 Financial Results and Provides Pipeline Update
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/28/2014)... , July 28, 2014  VigeneTech, Inc, ... release of LEGENDplex™ Data Analysis Software, an OEM ... flow cytometers.  BioLegend develops and offers varieties of ... cytometers. With the support of VigeneTech,s data analysis ... accurately analyzed and easily reported ...
    (Date:7/28/2014)... , July 28, 2014  UBM Medica US announces ... online community for medical imaging professionals, explored the complex ... payment models . The shift from fee-for-service ... how the radiologist,s reimbursement is determined in the new ... from leaders in the field, who recognized the complexity ...
    (Date:7/28/2014)... BIRMINGHAM, Ala. , July 28, 2014 /PRNewswire-USNewswire/ ... Arthur J. Tipton , Ph.D., President and CEO ... of the Controlled Release Society (CRS) for the ... Society,s annual meeting on July 12 in ... than 40 countries.  The Controlled ...
    Breaking Medicine Technology:VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2Diagnostic Imaging Delves into Measuring the Radiologist's Value 2Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 2Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 3
    ... Incorporated (NYSE: DGX ), the world,s leading ... it is scheduled to speak at the Jefferies 2011 ... is scheduled for Monday, June 6, 2011 at 8:30 ... webcast live during the conference and will be available ...
    ... ANN ARBOR, Mich., June 3, 2011 Everist Genomics ... OncoDefender-CRC assay, a molecular prognostic test for early-stage colorectal ... Society of Clinical Oncology (ASCO) Annual Meeting, which will ... (Logo: http://photos.prnewswire.com/prnh/20110110/NY26865LOGO ) OncoDefender-CRC examines expression ...
    Cached Medicine Technology:Everist Genomics Announces New Data on OncoDefender™- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients 2Everist Genomics Announces New Data on OncoDefender™- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients 3Everist Genomics Announces New Data on OncoDefender™- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients 4
    (Date:7/28/2014)... A young couple from a small ... in the media today about parents accidentally leaving children ... of minutes in a hot car. July 31 is ... Emergency Medical Services at NHTSA. , Shaun and Kimberly ... that it’s all too easy to get distracted, the ...
    (Date:7/28/2014)... Mediaplanet announced distribution of ... 12th, a campaign that aims to raise awareness about ... industry leader TEALUX , a premium loose leaf ... campaign provides readers with educational insight about the accessibility ... the industry forward and make conscious organic choices an ...
    (Date:7/28/2014)... (PRWEB) July 28, 2014 The website, ... for the healthcare industry, went live in January 2014. ... the basic standards of excellence that comprise the web’s ... excellence in Healthcare. , “What pleases me the most ... content and usability categories,” said Joshua Snow, web manager, ...
    (Date:7/28/2014)... According to a new market research ... IV-IV, sapphire), Deposition Technology (CVD, MBE, HVPE, ... and Geography-2013-2020", published by MarketsandMarkets, the market is ... from 2014 to 2020 and reach $104.55 billion ... and 88 figures spread through 342 pages and ...
    (Date:7/28/2014)... Lake City, Utah (PRWEB) July 28, 2014 Irresistible ... gift delivered by Spoonful of Comfort. The online gifting company specializes ... they are practical. , The New Baby package starts with home-from-the-hospital ... jar of soup , 6 rolls , ... smiles , The soup is ready to heat and ...
    Breaking Medicine News(10 mins):Health News:'Precious Cargo' App Released to Help Save Babies from the Dangers of Being Accidentally Left Behind in Hot Cars 2Health News:Mediaplanet's "Organic Living" Campaign Raises Awareness About What Nature Invented, With the Help of Partner TEALUX 2Health News:Abington Health Website Named Best in Class 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 3Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 4Health News:Spoonful of Comfort Announces "New Baby" Gift Package 2
    ... concerns about erosion of RN and patient care ... today criticized the action by the Service Employees ... affiliate, United Healthcare Workers-West.In a statement today, Rose ... registered nurses in most of the hospitals where ...
    ... called astrocytes help to cause the urge to sleep that ... funded by the National Institutes of Health. The cells ... are inhibited by caffeine. , "Millions of Americans suffer from ... from pilots to combat soldiers have jobs where sleepiness ...
    ... Wednesday,s winter storm has impacted the blood ... blood drives were cancelled or postponed on Wednesday ... appointments, resulting in a 32.5% reduction of Penn-Jersey ... 6 blood drives that were scheduled to collect ...
    ... help spread awareness of Foundation,s mission and servicesSHORT HILLS, ... Foundation, the national, non-profit organization dedicated to finding cures ... lives of people living with paralysis, announced today that ... show "Brothers and Sisters," has been named a celebrity ...
    ... over 20 now have the condition, while 30% are pre-diabetic, ... most recent analysis of data on diabetes in the United ... and older have the condition, 40 percent of whom have ... patients than noted in a previous study, although the percentage ...
    ... Washington, D.C. A three-year award from the ... of Population Affairs to Georgetown University,s Institute for ... in California and Massachusetts to offer the Standard ... planning method developed by Institute researchers. , In ...
    Cached Medicine News:Health News:CNA/NNOC Criticizes SEIU Trusteeship: Cites Concerns for Erosion of RN and Patient Care Standards 2Health News:Support cells, not neurons, lull the brain to sleep 2Health News:Support cells, not neurons, lull the brain to sleep 3Health News:Blood Donors Needed in Wake of Winter Storm 2Health News:Dave Annable Named Christopher & Dana Reeve Foundation Ambassador 2Health News:Diabetes Keeps Rising Among U.S. Adults 2Health News:Diabetes Keeps Rising Among U.S. Adults 3Health News:Bringing easy-to-use, effective natural family planning to American women 2
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: